Avient Colorants Indonesia Gatot Subroto Km. 4, Jl. Ltd. 30, Hsing Pang Road Taoyuan 33068 Taiwan Facility: Avient Colorants Thailand Ltd. Facility: Avient Colorants USA LLC 337 Timber Road Mooresville, NC 28115 U.S.A.

Feb 18, 2025 This reduction in weight allows trucks to move withgreater fuel efficiency, and fewer trucks are needed on the road in general.

Additionally, other standard portfolios, such as colors for ophthalmic closures or white for pharmaceutical packaging, help fast-track the coloration of specific healthcare applications. APPLICATION PORTFOLIO DESCRIPTION General use Opaque and transparent colors in PP, PE, COC, ABS, POM, PC, TPU, PEEK, and more Needle hubs and cannulae Opaque and translucent colors evaluated to ISO 6009 Ophthalmic caps and closures 13 standard colors in PE matched to American Academy of Ophthalmology; biologically evaluated to USP standard White pharmaceutical packaging White colorants for PE, HDPE, PP covering solid dose to nasal packaging needs Amber pharmaceutical packaging Pre-tested amber colorants LSR silicones For LSR silicones and transparent color PET/PP (e.g. amber) FUNCTIONALITY ADDITIVE PERFORMANCE UV protection in transparent packaging Blocks UV in 290–450nm for PP, PE, PETG, COP Processing aid/friction reduction Optimizes processing for PE, PP, ABS, POM—non-migrating Nucleation for reduced material consumption/cycle time Improves thermal and mechanical properties of PE and PP and allows wall thinning to support sustainability Clarifying Improves clarity of transparent PP applications with reduced migration and improved thermal stability—sorbitol-free Laser marking/welding Activates the polymer to absorb Nd-YAG laser for fast reliable marking/assembly Gamma/e-beam sterilization Preserves the properties of PP and COP, reduces yellowing and compensates for discoloration Anti-static Reduces static buildup in applications such as films in API handling and inhaler spacers/nebulizers Antioxidant Provides thermal protection during converting/ downstream sterilization Anti-counterfeit/brand protection Covert and non-covert systems SUPPORTING SUSTAINABILITY TARGETS As the need to integrate sustainability in the design of healthcare products is growing, manufacturers of medical devices, diagnostic products and pharmaceutical packaging are looking for materials with a more environmentally friendly profile.

APPLICATIONS • Consumer products such as sporting goods, toys, boxes, pet accessories • Packaging bottles, containers and closures • Appliances, electronics and electrical housings • Automotive interior and exterior trim components BENEFITS • Includes a wide range of special effects for increased visual impact and differentiation • Eliminates the need for secondary processing like painting or decorating • Can be combined with performance additives into Smartbatch™ solutions for convenience Copyright © 2024, Avient Corporation.

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $39.28 April 4th, 2014 • 18 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 6 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target A dj us te d Ea rn in gs P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 7 PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% Mix Shift Highlights Specialty Transformation Page 8 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 Q1 2014 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target 2015 Target Proof of Performance & 2015 Goals Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double DigitExpansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 42.0% 2006 Q1 2014 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Investing in operational and initiatives that drive profitability growth  Manufacturing realignment  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

2 Подкуп государственных должностных лиц 2 Коммерческий подкуп 3 Платежи за упрощение формальностей и откаты 3 Работа с агентами, дистрибьюторами и иными третьими сторонами 3 Процедура комплексной проверки и процесс одобрения 4 Тревожные признаки 4 Требования к делопроизводству и бухгалтерскому учету 4 Фиксация возможных нарушений 5 Горячая линия по вопросам этики компании Avient 5 Защита от преследований 5 Краткий справочник: ЧТО СЛЕДУЕТ И ЧТО НЕ СЛЕДУЕТ ДЕЛАТЬ СОГЛАСНО АНТИМОНОПОЛЬНЫМ ЗАКОНАМ 6 1 Наша глобальная политика по борьбе с коррупцией и взяточничеством Компания Avient строго запрещает мошенничество, взяточничество и другие коррупционные практики при ведении бизнеса в любой точке мира. subject= 4 Поэтому важно проводить комплексную проверку благонадежности агентов и прочих третьих сторон компании Avient, как до их привлечения, так и в ходе взаимодействия. Эйвон-Лейк, США 33587 Walker Road Avon Lake, OH, United States 44012 Бесплатный тел.: +1-866-765-9663 Телефон: +1-440-930-1000 Факс: +1-440 930 3064 Азиатско-Тихоокеанский регион Региональный офис в Шанхае, Китай 2F, Block C 200 Jinsu Road Pudong, 201206 Shanghai, China Телефон: +86 (0) 21 6028 4888 Факс: +86 (0) 21 6028 4999 Южная Америка Региональный офис в Сан-Паулу, Бразилия Av.

May 14, 2025 May 14, 2025 May 06, 2025

May 14, 2025 May 14, 2025 May 06, 2025

Here are 4 key trends, and how you can use them to create products that will resonate with present-day pet owners. In fact, identification and tracking are emerging as the largest application segment with sales expected to reach $2.2 billion by 2025*.

RTF Template P lac e and date: For the is s uing offic e: Shanghai, 30 March, 2018 DNV GL – Business A ssurance Suite A , Building 9, No.1591 Hongqiao Road, Changning District, Shanghai 200336, P.R. TEL:+31102922689. assurance. dnvgl.com C ertificate N o: 1 6 1 4-2000-AE-RGC-RvA I nitial c ertification date: 2 3 M ay, 2 0 00 V alid: 2 3 M ay, 2 0 18 - 2 3 May, 2 021 This is to certify that the management system of PolyOne-Shanghai, China No. 88, Guo Shou Jing Road, Z.